Fig. 7: Analysis and detection of ferroptosis-related genes and serum indicators in human CCa.
From: A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signaling
A Expression distribution of ferroptosis-related genes in human CCa tissues and normal tissues. Significant differences between two groups were identified by the Wilcoxon test; significant differences among the three groups were identified by Kruskal–Wallis test. Asterisks (*) indicate significance levels: *P < 0.05, **P < 0.01, ***P < 0.001. B Serum Hcy values in healthy, CIN and CCa patients. (t tests, *P < 0.05, ***P < 0.001). C Serum G-SH values in healthy control (n = 52), CIN (n = 48), and CCa (n = 50) patients. (t tests, *P < 0.05, ***P < 0.001). D Serum Fe2+ values in healthy control (n = 52), CIN (n = 48) and CCa (n = 50) patients. (t tests, ***P < 0.001).
